Position in REGN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$89,007,355
-$15,887,541 QoQ
Shares Held
115,199
+15.4% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JENNISON ASSOCIATES LLC holds $3,761,825,691 across 45 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,998,530 | $1,489,459,806 | |
| 2 | ARGX |
Argenx SE
|
226,200 | $209,861,574 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
4,481,964 | $158,616,705 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
960,619 | $146,801,794 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
1,151,681 | $141,173,056 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,358,587 | $129,722,285 | |
| 7 | IMVT |
Immunovant, Inc.
|
3,310,238 | $127,543,470 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
4,219,058 | $110,623,700 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $89,007,355 | 115,199 | Shares | Defined | 2026-05-06 | |
| 2024-06-30 | $104,894,896 | 99,802 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $32,263,627 | 33,521 | Shares | Defined | 2024-05-02 | |
| 2023-03-31 | $23,080,710 | 28,090 | Shares | Defined | 2023-04-26 | |
| 2021-09-30 | $1,092,349 | 1,805 | Shares | Defined | 2021-11-09 | |
| 2021-03-31 | $4,760,261 | 10,061 | Shares | Defined | 2021-05-11 | |
| 2020-09-30 | $37,440,325 | 66,884 | Shares | Defined | 2020-11-04 | |
| 2020-06-30 | $42,755,573 | 68,557 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $22,656,656 | 46,400 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||